Skip to main content
. 2018 Mar;47(3):317–326.

Table 2:

The prevalence of imipenem and ceftazidime resistance among Klebsiella pneumoniae

Subgroups No. of study Prevalence of drug resistance (95% CI) n/N* Heterogeneity Test Egger’s test for publication bias
I2 (%) P-value t P-value
Overall effects of resistant to imipenem 16 3.2 (1.5–6.5) 46/1182 75.9 <.001 5.1 0.00016
Overall effects of resistant to ceftazidime 24 55.7 (46.9–64.1) 841/1686 92.2 <.001 2.4 0.02454

CI, confidence interval; n, number of events (drug resistance); N, total number of Klebsiella pneumoniae from the included studies